• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定人类黄嘌呤脱氢酶基因中导致经典I型黄嘌呤尿症的两个突变。

Identification of two mutations in human xanthine dehydrogenase gene responsible for classical type I xanthinuria.

作者信息

Ichida K, Amaya Y, Kamatani N, Nishino T, Hosoya T, Sakai O

机构信息

Second Department of Medicine, The Jikei University School of Medicine, Tokyo 105.

出版信息

J Clin Invest. 1997 May 15;99(10):2391-7. doi: 10.1172/JCI119421.

DOI:10.1172/JCI119421
PMID:9153281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC508078/
Abstract

Hereditary xanthinuria is classified into three categories. Classical xanthinuria type I lacks only xanthine dehydrogenase activity, while type II and molybdenum cofactor deficiency also lack one or two additional enzyme activities. In the present study, we examined four individuals with classical xanthinuria to discover the cause of the enzyme deficiency at the molecular level. One subject had a C to T base substitution at nucleotide 682 that should cause a CGA (Arg) to TGA (Ter) nonsense substitution at codon 228. The duodenal mucosa from the subject had no xanthine dehydrogenase protein while the mRNA level was not reduced. The two subjects who were siblings with type I xanthinuria were homozygous concerning this mutation, while another subject was found to contain the same mutation in a heterozygous state. The last subject who was also with type I xanthinuria had a deletion of C at nucleotide 2567 in cDNA that should generate a termination codon from nucleotide 2783. This subject was homozygous for the mutation and the level of mRNA in the duodenal mucosa from the subject was not reduced. Thus, in three subjects with type I xanthinuria, the primary genetic defects were confirmed to be in the xanthine dehydrogenase gene.

摘要

遗传性黄嘌呤尿症分为三类。经典的I型黄嘌呤尿症仅缺乏黄嘌呤脱氢酶活性,而II型和钼辅因子缺乏症还缺乏一种或两种其他酶活性。在本研究中,我们检查了四名患有经典黄嘌呤尿症的个体,以在分子水平上发现酶缺乏的原因。一名受试者在核苷酸682处发生了C到T的碱基替换,这应该导致密码子228处的CGA(精氨酸)到TGA(终止)无义替换。该受试者的十二指肠粘膜没有黄嘌呤脱氢酶蛋白,而mRNA水平没有降低。两名患有I型黄嘌呤尿症的同胞受试者在该突变方面是纯合子,而另一名受试者被发现以杂合状态含有相同的突变。最后一名同样患有I型黄嘌呤尿症的受试者在cDNA的核苷酸2567处缺失了C,这应该从核苷酸2783产生一个终止密码子。该受试者在该突变方面是纯合子,并且该受试者十二指肠粘膜中的mRNA水平没有降低。因此,在三名I型黄嘌呤尿症受试者中,主要的遗传缺陷被证实存在于黄嘌呤脱氢酶基因中。

相似文献

1
Identification of two mutations in human xanthine dehydrogenase gene responsible for classical type I xanthinuria.鉴定人类黄嘌呤脱氢酶基因中导致经典I型黄嘌呤尿症的两个突变。
J Clin Invest. 1997 May 15;99(10):2391-7. doi: 10.1172/JCI119421.
2
Mutation of human molybdenum cofactor sulfurase gene is responsible for classical xanthinuria type II.人类钼辅因子硫酸化酶基因突变是导致经典II型黄嘌呤尿症的原因。
Biochem Biophys Res Commun. 2001 Apr 20;282(5):1194-200. doi: 10.1006/bbrc.2001.4719.
3
Effect of allopurinol on the xanthinuria in a patient with molybdenum cofactor deficiency.别嘌醇对钼辅因子缺乏患者黄嘌呤尿症的影响。
Adv Exp Med Biol. 1994;370:375-8. doi: 10.1007/978-1-4615-2584-4_81.
4
Identification of a new point mutation in the human molybdenum cofactor sulferase gene that is responsible for xanthinuria type II.鉴定人类钼辅因子硫酶基因中一个导致Ⅱ型黄嘌呤尿症的新点突变。
Metabolism. 2003 Nov;52(11):1501-4. doi: 10.1016/s0026-0495(03)00272-5.
5
Identification of a new point mutation in the human xanthine dehydrogenase gene responsible for a case of classical type I xanthinuria.鉴定人类黄嘌呤脱氢酶基因中的一个新的点突变,该突变导致一例典型的I型黄嘌呤尿症。
Hum Genet. 2001 Apr;108(4):279-83. doi: 10.1007/s004390100477.
6
[Hereditary xanthinuria and molybdenum cofactor deficiency].[遗传性黄嘌呤尿症和钼辅因子缺乏症]
Nihon Rinsho. 2003 Jan;61 Suppl 1:377-82.
7
Identification and characterization of the first mutation (Arg776Cys) in the C-terminal domain of the Human Molybdenum Cofactor Sulfurase (HMCS) associated with type II classical xanthinuria.与II型经典黄嘌呤尿症相关的人钼辅因子硫酶(HMCS)C末端结构域中首个突变(Arg776Cys)的鉴定与特征分析。
Mol Genet Metab. 2007 May;91(1):23-9. doi: 10.1016/j.ymgme.2007.02.005. Epub 2007 Mar 23.
8
Mutations in xanthine dehydrogenase gene in subjects with hereditary xanthinuria.患有遗传性黄嘌呤尿症患者的黄嘌呤脱氢酶基因突变。
Adv Exp Med Biol. 1998;431:327-30. doi: 10.1007/978-1-4615-5381-6_65.
9
[Xanthine oxidase deficiency (hereditary xanthinuria), molybdenum cofactor deficiency].[黄嘌呤氧化酶缺乏症(遗传性黄嘌呤尿症),钼辅因子缺乏症]
Nihon Rinsho. 1996 Dec;54(12):3333-6.
10
Mutational analysis of the xanthine dehydrogenase gene in a Turkish family with autosomal recessive classical xanthinuria.一个患有常染色体隐性经典黄嘌呤尿症的土耳其家族中黄嘌呤脱氢酶基因的突变分析。
Nephrol Dial Transplant. 2003 Nov;18(11):2278-83. doi: 10.1093/ndt/gfg385.

引用本文的文献

1
A prevalent MOCS2 variant in the Roma population is associated with a novel mild form of molybdenum cofactor deficiency.罗姆人群中一种常见的MOCS2变体与一种新型轻度钼辅因子缺乏症相关。
Eur J Pediatr. 2025 Jul 25;184(8):499. doi: 10.1007/s00431-025-06335-x.
2
Pseudogenization of the Slc23a4 gene is necessary for the survival of Xdh-deficient mice.Slc23a4基因的假基因化对于缺乏Xdh的小鼠的存活是必要的。
Sci Rep. 2025 Jan 25;15(1):3250. doi: 10.1038/s41598-025-87751-9.
3
Potential Opportunities for Pharmacogenetic-Based Therapeutic Exploitation of Xanthine Dehydrogenase in Cardiovascular Disease.基于药物遗传学对黄嘌呤脱氢酶在心血管疾病中进行治疗性开发的潜在机会。
Antioxidants (Basel). 2024 Nov 22;13(12):1439. doi: 10.3390/antiox13121439.
4
Emerging Roles of Xanthine Oxidoreductase in Chronic Kidney Disease.黄嘌呤氧化还原酶在慢性肾脏病中的新作用
Antioxidants (Basel). 2024 Jun 12;13(6):712. doi: 10.3390/antiox13060712.
5
Xanthinuria in a familial group of Munchkin cats and an unrelated domestic shorthair cat.黄嘌呤尿症在一个芒奇金猫的家族群和一只不相关的家养短毛猫中。
J Feline Med Surg. 2024 May;26(5):1098612X241241408. doi: 10.1177/1098612X241241408.
6
Monogenic features of urolithiasis: A comprehensive review.尿石症的单基因特征:全面综述
Asian J Urol. 2024 Apr;11(2):169-179. doi: 10.1016/j.ajur.2023.03.004. Epub 2023 Jun 5.
7
Dysuricemia.排尿障碍血症
Biomedicines. 2023 Nov 28;11(12):3169. doi: 10.3390/biomedicines11123169.
8
Three cases of xanthinuria identified by gas chromatography/mass spectrometry-based urine metabolomics.通过基于气相色谱/质谱的尿液代谢组学鉴定出三例黄嘌呤尿症病例。
IJU Case Rep. 2023 Sep 28;6(6):436-439. doi: 10.1002/iju5.12642. eCollection 2023 Nov.
9
Computational Characterization of the Inhibition Mechanism of Xanthine Oxidoreductase by Topiroxostat.托匹司他对黄嘌呤氧化还原酶抑制机制的计算表征
ACS Catal. 2023 May 5;13(9):6023-6043. doi: 10.1021/acscatal.3c01245. Epub 2023 Apr 18.
10
Declaration: Novel SLC3A1 mutation in a cystinuria patient with xanthine stones: a case report.声明:一例黄嘌呤结石胱氨酸尿症患者的 SLC3A1 新突变:病例报告。
BMC Urol. 2023 Jul 31;23(1):130. doi: 10.1186/s12894-023-01300-y.

本文引用的文献

1
Xanthinuria, an inborn error (or deviation) of metabolism.黄嘌呤尿症,一种先天性代谢错误(或偏差)。
Lancet. 1954 Jan 23;266(6804):182-5. doi: 10.1016/s0140-6736(54)91257-x.
2
Adenine phosphoribosyltransferase deficiency identified by urinary sediment analysis: cellular and molecular confirmation.通过尿沉渣分析鉴定腺嘌呤磷酸核糖转移酶缺乏症:细胞和分子层面的确认
Clin Genet. 1995 Nov;48(5):246-50. doi: 10.1111/j.1399-0004.1995.tb04098.x.
3
Cloning and expression in vitro of human xanthine dehydrogenase/oxidase.人黄嘌呤脱氢酶/氧化酶的克隆及体外表达
Biochem J. 1996 Apr 1;315 ( Pt 1)(Pt 1):235-9. doi: 10.1042/bj3150235.
4
Molecular cloning and characterization of the human xanthine dehydrogenase gene (XDH).人类黄嘌呤脱氢酶基因(XDH)的分子克隆与特性分析
Genomics. 1996 Jun 1;34(2):173-80. doi: 10.1006/geno.1996.0262.
5
Superoxide radical and xanthine oxidoreductase activity in the human heart during cardiac operations.
Ann Thorac Surg. 1995 Nov;60(5):1289-93. doi: 10.1016/0003-4975(95)00616-S.
6
cDNA cloning, characterization, and tissue-specific expression of human xanthine dehydrogenase/xanthine oxidase.人黄嘌呤脱氢酶/黄嘌呤氧化酶的cDNA克隆、特性鉴定及组织特异性表达
Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10690-4. doi: 10.1073/pnas.90.22.10690.
7
Cloning of the cDNA encoding human xanthine dehydrogenase (oxidase): structural analysis of the protein and chromosomal location of the gene.编码人黄嘌呤脱氢酶(氧化酶)的cDNA的克隆:蛋白质的结构分析及该基因的染色体定位
Gene. 1993 Nov 15;133(2):279-84. doi: 10.1016/0378-1119(93)90652-j.
8
Mapping of the gene for human xanthine dehydrogenase (oxidase) (XDH) to band p23 of chromosome 2.
Cytogenet Cell Genet. 1995;68(1-2):52-3. doi: 10.1159/000133887.
9
Flavoprotein structure and mechanism. 4. Xanthine oxidase and xanthine dehydrogenase.黄素蛋白的结构与机制。4. 黄嘌呤氧化酶和黄嘌呤脱氢酶。
FASEB J. 1995 Aug;9(11):995-1003.
10
Properties of rabbit liver aldehyde oxidase and the relationship of the enzyme to xanthine oxidase and dehydrogenase.兔肝醛氧化酶的特性及其与黄嘌呤氧化酶和脱氢酶的关系。
Eur J Biochem. 1995 Sep 1;232(2):646-57.